Skip to Main Content

Author Details

Manway Liu
Verily Life Sciences LLC
2007
19
18
PMIDPaper TitleJournal TitlePublished Year
30559381Addendum: The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity.Nature2019
31840094Quantifying neurologic disease using biosensor measurements in-clinic and in free-living settings in multiple sclerosis.NPJ Digit Med2019
30559381Addendum: The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity.Nature2019
30304439CANDI: an R package and Shiny app for annotating radiographs and evaluating computer-aided diagnosis.Bioinformatics2019
31068700Next-generation characterization of the Cancer Cell Line Encyclopedia.Nature2019
31304378Deep learning predicts hip fracture using confounding patient and healthcare variables.NPJ Digit Med2019
31840094Quantifying neurologic disease using biosensor measurements in-clinic and in free-living settings in multiple sclerosis.NPJ Digit Med2019
31304378Deep learning predicts hip fracture using confounding patient and healthcare variables.NPJ Digit Med2019
31068700Next-generation characterization of the Cancer Cell Line Encyclopedia.Nature2019
30304439CANDI: an R package and Shiny app for annotating radiographs and evaluating computer-aided diagnosis.Bioinformatics2019
30399157Variable generalization performance of a deep learning model to detect pneumonia in chest radiographs: A cross-sectional study.PLoS Med2018
30399157Variable generalization performance of a deep learning model to detect pneumonia in chest radiographs: A cross-sectional study.PLoS Med2018
27689005Defects in muscle branched-chain amino acid oxidation contribute to impaired lipid metabolism.Mol Metab2016
27689005Defects in muscle branched-chain amino acid oxidation contribute to impaired lipid metabolism.Mol Metab2016
25724664Loss of Tuberous Sclerosis Complex 2 (TSC2) Is Frequent in Hepatocellular Carcinoma and Predicts Response to mTORC1 Inhibitor Everolimus.Mol Cancer Ther2015
25873175AXL mediates resistance to PI3Kα inhibition by activating the EGFR/PKC/mTOR axis in head and neck and esophageal squamous cell carcinomas.Cancer Cell2015
25724664Loss of Tuberous Sclerosis Complex 2 (TSC2) Is Frequent in Hepatocellular Carcinoma and Predicts Response to mTORC1 Inhibitor Everolimus.Mol Cancer Ther2015
25873175AXL mediates resistance to PI3Kα inhibition by activating the EGFR/PKC/mTOR axis in head and neck and esophageal squamous cell carcinomas.Cancer Cell2015
24062244Carboxyl-ester lipase maturity-onset diabetes of the young is associated with development of pancreatic cysts and upregulated MAPK signaling in secretin-stimulated duodenal fluid.Diabetes2014
24062244Carboxyl-ester lipase maturity-onset diabetes of the young is associated with development of pancreatic cysts and upregulated MAPK signaling in secretin-stimulated duodenal fluid.Diabetes2014
24608574Characterization of the novel and specific PI3Kα inhibitor NVP-BYL719 and development of the patient stratification strategy for clinical trials.Mol Cancer Ther2014
25002028CDK 4/6 inhibitors sensitize PIK3CA mutant breast cancer to PI3K inhibitors.Cancer Cell2014
25002028CDK 4/6 inhibitors sensitize PIK3CA mutant breast cancer to PI3K inhibitors.Cancer Cell2014
24608574Characterization of the novel and specific PI3Kα inhibitor NVP-BYL719 and development of the patient stratification strategy for clinical trials.Mol Cancer Ther2014
23493311The HSP90 inhibitor NVP-AUY922 potently inhibits non-small cell lung cancer growth.Mol Cancer Ther2013
23903756mTORC1 inhibition is required for sensitivity to PI3K p110α inhibitors in PIK3CA-mutant breast cancer.Sci Transl Med2013
23493311The HSP90 inhibitor NVP-AUY922 potently inhibits non-small cell lung cancer growth.Mol Cancer Ther2013
23903756mTORC1 inhibition is required for sensitivity to PI3K p110α inhibitors in PIK3CA-mutant breast cancer.Sci Transl Med2013
22460905The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity.Nature2012
22539746mTOR inhibitors synergize on regression, reversal of gene expression, and autophagy in hepatocellular carcinoma.Sci Transl Med2012
22460905The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity.Nature2012
22539746mTOR inhibitors synergize on regression, reversal of gene expression, and autophagy in hepatocellular carcinoma.Sci Transl Med2012
20713682A systems biology approach identifies inflammatory abnormalities between mouse strains prior to development of metabolic disease.Diabetes2010
20713682A systems biology approach identifies inflammatory abnormalities between mouse strains prior to development of metabolic disease.Diabetes2010
19208909Accelerated postnatal growth increases lipogenic gene expression and adipocyte size in low-birth weight mice.Diabetes2009
19208909Accelerated postnatal growth increases lipogenic gene expression and adipocyte size in low-birth weight mice.Diabetes2009
17571924Network-based analysis of affected biological processes in type 2 diabetes models.PLoS Genet2007
17571924Network-based analysis of affected biological processes in type 2 diabetes models.PLoS Genet2007
  • 1 - 38 of 38

Recommended Authors

Simon Koplev
Cancer Research UK Cambridge Institute, University of Cambridge
Career Start Year 2016
Number of shared co-authors 3
Zichen Wang
Icahn School of Medicine at Mount Sinai
Career Start Year 2013
Number of shared co-authors 4
James A Eddy
Benaroya Research Institute at Virginia Mason, Institute for Systems Biology, Sage Bionetworks, University of Illinois at Urbana-Champaign
Career Start Year 2008
Number of shared co-authors 1
Michiel E Adriaens
Maastricht University
Career Start Year 2008
Number of shared co-authors 0
Yuanfang Guan
University of Michigan ann arbor
Career Start Year 2007
Number of shared co-authors 7
Andrew T Magis
Institute for Systems Biology
Career Start Year 2007
Number of shared co-authors 0
Eunjee Lee
Chungnam National University
Career Start Year 2007
Number of shared co-authors 2
Jing Chen
College of Bioinformatics Science and Technology, Harbin Medical University
Career Start Year 2007
Number of shared co-authors 1
Jennifer Clarke
Department of Food Science and Technology, University of Nebraska-Lincoln
Career Start Year 2006
Number of shared co-authors 0
Marco Chierici
Fondazione Bruno Kessler
Career Start Year 2006
Number of shared co-authors 0
Avi Ma'ayan
Icahn School of Medicine at Mount Sinai
Career Start Year 2005
Number of shared co-authors 7
Arnaud Droit
Centre de Recherche du CHU de Quebec-Universite, Universite Laval
Career Start Year 2005
Number of shared co-authors 0
Richard A Moffitt
Stony Brook University, and Stony Brook Cancer Center
Career Start Year 2005
Number of shared co-authors 6
Han-Yu Chuang
Departments of Bioinformatics and Clinical Genomics, Illumina Inc.
Career Start Year 2005
Number of shared co-authors 1
Guanghua Xiao
The University of Texas Southwestern Medical Center
Career Start Year 2005
Number of shared co-authors 6
Bin Zhang
Graduate School of Medicine, The University of Tokyo
Career Start Year 2004
Number of shared co-authors 5
Ted Laderas
Oregon Health & Science University
Career Start Year 2003
Number of shared co-authors 0
Zhandong Liu
Jan and Dan Duncan Neurological Research Institute at Texas Children's Hospital
Career Start Year 2003
Number of shared co-authors 0
Max Kotlyar
Schroeder Arthritis Institute
Career Start Year 2002
Number of shared co-authors 1
Mikhail G Dozmorov
Virginia Commonwealth University
Career Start Year 2001
Number of shared co-authors 0
Jean Yee Hwa Yang
The University of Sydney
Career Start Year 2001
Number of shared co-authors 0
Yan W Asmann
Mayo Clinic
Career Start Year 2000
Number of shared co-authors 6
Tero Aittokallio
Institute for Molecular Medicine Finland (FIMM), University of Helsinki
Career Start Year 1999
Number of shared co-authors 8
Kerby Shedden
University of Michigan ann arbor
Career Start Year 1999
Number of shared co-authors 3
Cory C Funk
Institute for Systems Biology
Career Start Year 1999
Number of shared co-authors 1
Jeffrey S Morris
Perelman School of Medicine, University of Pennsylvania
Career Start Year 1999
Number of shared co-authors 3
Igor Jurisica
Schroeder Arthritis Institute
Career Start Year 1998
Number of shared co-authors 4
Eric E Schadt
Icahn School of Medicine at Mount Sinai
Career Start Year 1998
Number of shared co-authors 5
Shannon K McWeeney
Oregon Health & Science University, University of California Berkeley
Career Start Year 1997
Number of shared co-authors 0
Atul J Butte
Bakar Computational Health Sciences Institute, University of California san francisco
Career Start Year 1993
Number of shared co-authors 11

Collaborators

Joseph Lehár
Co-authored papers 7
Robert Schlegel
Co-authored papers 6
Simon Kasif
Boston University
Co-authored papers 4
Anupama Reddy
Co-authored papers 4
Jordi Barretina
Co-authored papers 3
Judit Jané-Valbuena
Co-authored papers 3
Marcus A Badgeley
Co-authored papers 3
Michael Morrissey
Co-authored papers 3
Dmitriy Sonkin
National Cancer Institute
Co-authored papers 3
Gregory V Kryukov
Co-authored papers 3
Giordano Caponigro
Co-authored papers 3
Todd R Golub
Broad Institute of MIT and Harvard
Co-authored papers 3
Michael D Jones
Co-authored papers 3
Gad Getz
Broad Institute of the Massachusetts Institute of Technology and Harvard
Co-authored papers 3
Kavitha Venkatesan
Co-authored papers 3
Levi A Garraway
Broad Institute of Harvard and MIT
Co-authored papers 3
Nicolas Stransky
Co-authored papers 3
Jill P Mesirov
University of California San Diego
Co-authored papers 2
Robert C Onofrio
The Broad Institute of Harvard and MIT
Co-authored papers 2
Jill Cheng
Co-authored papers 2
Michael F Berger
Co-authored papers 2
Christopher J Wilson
Co-authored papers 2
Adam Korejwa
Co-authored papers 2
Michael V McConnell
Co-authored papers 2
William R Sellers
Co-authored papers 2
Lauren Murray
Co-authored papers 2
Markus Warmuth
Co-authored papers 2
Matthew Meyerson
Broad Institute
Co-authored papers 2
Barbara L Weber
Basser Center for BRCA, Abramson Cancer Center, University of Pennsylvania
Co-authored papers 2
José Baselga
Co-authored papers 2
Release 1.2